カート
レポートナンバー 0000039322
VPGMarketResearch
2024 Japan Hospital Microbiology Market for 100 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
発刊日 2024/08/21
言語英語
体裁PDF
ライセンス/価格
0000039322
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。 ※本レポートは、英文です。電子媒体での納品となります。 ※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
無料サンプル
この新しいレポートは、日本の病院微生物検査市場に関する以下の包括的な分析を提供します。
Table of Contents Introduction Worldwide Market and Technology Overview A. Major Infectious Disease Tests 1. AIDS a. Background b. Diagnostic Tests c. Vaccines and Drugs 2. Adenovirus a. Background b. Diagnostic Tests c. Vaccines and Drugs d. Adeno-Associated Viruses(AAV) 3. Aeromonas a. Background b. Diagnostic Tests c. Vaccines and Drugs 4. Anthrax/Bacillus Anthracis a. Background b. Diagnostic Tests c. Vaccines and Drugs 5. Arboviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 6. Babesiosis a. Background 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea) a. Background b. Diagnostic Tests c. Vaccines and Drugs 8. Blastocystis Hominis a. Background b. Diagnostic Tests c. Vaccines and Drugs 9. Brucella a. Background b. Diagnostic Tests c. Vaccines and Drugs 10. Campylobacter a. Background b. Diagnostic Tests c. Vaccines and Drugs 11. Candida a. Background b. Diagnostic Tests c. Vaccines and Drugs 12. Chagas Disease a. Background 13. Chancroid a. Background b. Diagnostic Tests c. Vaccines and Drugs 14. Chlamydia a. Background b. Diagnostic Tests c. Vaccines and Drugs 15. Clostridium Difficile a. Background b. Diagnostic Tests c. Drugs and Vaccines 16. Coronaviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 17. Coxsackieviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 18. Creutzfeldt-Jakob’s Disease a. Background b. Diagnostic Tests c. Vaccines 19. Cryptosporidium Parvum a. Background b. Diagnostic Tests c. Vaccines and Drugs 20. Cyclospora Cayetanensis a. Background b. Diagnostic Tests c. Vaccines and Drugs 21. Cytomegalovirus a. Background b. Diagnostic Tests c. Vaccines and Drugs 22. Ebola Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 23. E. Coli a. Background b. Diagnostic Tests c. Vaccines and Drugs 24. EchoVirus a. Background b. Diagnostic Tests c. Vaccines and Drugs 25. Encephalitis a. Background b. Diagnostic Tests c. Vaccines and Drugs 26. Enteroviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 27. Epstein-Barr Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 28. Giardia Lamblia a. Background b. Diagnostic Tests c. Vaccines and Drugs 29. Gonorrhea a. Background b. Diagnostic Tests c. Vaccines and Drugs 30. Granuloma Inguinale a. Background b. Diagnostic Tests c. Vaccines and Drugs 31. Hantavirus a. Background b. Diagnostic Tests c. Vaccines and Drugs 32. Helicobacter Pylori a. Background b. Diagnostic Tests c. Vaccines and Drugs 33. Hepatitis a. Background b. Hepatitis A c. Hepatitis B d. Hepatitis C e. Vaccines and Drugs 34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38. Lyme Disease a. Background b. Diagnostic Tests c. Vaccines and Drugs 39. Lymphogranuloma Venereum (LGV) a. Background b. Diagnostic Tests c. Vaccines and Drugs 40. Malaria a. Background b. Diagnostic Tests c. Vaccines and Drugs 41. Measles (Rubeola) a. Background b. Diagnostic Tests c. Vaccines and Drugs 42. Meningitis a. Background b. Diagnostic Tests c. Vaccines and Drugs 43. Microsporidium a. Background b. Diagnostic Tests c. Vaccines and Drugs 44. Mononucleosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 45. Mumps a. Background b. Diagnostic Tests c. Vaccines and Drugs 46. Mycoplasma a. Background b. Diagnostic Tests c. Vaccines and Drugs 47. Papillomaviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 48. Parvovirus B19 a. Background b. Diagnostic Tests c. Vaccines and Drugs 49. Pneumonia a. Background b. Diagnostic Tests c. Vaccines and Drugs 50. Polyomaviruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 51. Pseudomonas Aeruginosa a. Background b. Diagnostic Tests c. Vaccines and Drugs 52. Rabies a. Background b. Diagnostic Tests c. Vaccines and Drugs 53. Respiratory Syncytial Virus (RSV) a. Background b. Diagnostic Tests c. Vaccines and Drugs 54. RhinoViruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 55. RotaVirus (REOVIRUS) a. Background b. Diagnostic Tests c. Vaccines and Drugs 56. Rubella(MEASLES) a. Background b. Diagnostic Tests c. Vaccines and Drugs 57. Salmonellosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 58. Septicemia a. Background b. Diagnostic Tests c. Vaccines and Drugs 59. Shigellosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 60. Staphylococcus Aureus a. Background b. Diagnostic Tests c. Vaccines and Drugs 61. Streptococci a. Background b. Diagnostic Tests c. Vaccines and Drugs 62. Syphilis a. Background b. Diagnostic Tests c. Vaccines and Drugs 63. Toxoplasmosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 64. Trichomonas Vaginalis a. Background b. Diagnostic Tests c. Vaccines and Drugs 65. Tuberculosis a. Background b. Diagnostic Tests c. Vaccines and Drugs 66. Vibrio a. Background b. Diagnostic Tests c. Vaccines and Drugs 67. West Nile Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 68. Yersina a. Background b. Diagnostic Tests c. Vaccines and Drugs B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers C. Emerging Diagnostic Technologies 1. Molecular Diagnostics 2. Monoclonal Antibodies 3. Immunoassays 4. Differential Light Scattering 5. Information Technology 6. Artificial Intelligence 7. Liposomes 8. Flow Cytometry 9. Chromatography 10. Diagnostic Imaging 11. Gel Microdroplets 12. Other Japan A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers Major Product Development Opportunities A. Instrumentation B. Reagent Kits and Test Systems/Panels C. Computers, Software and Automation D. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Assessments - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Fujirebio - Grifols - GSK Biologicals - Hologic - Leica Biosystems - Lonza - Ortho-Clinical Diagnostics - PerkinElmer - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens Healthineers - Takara Bio - Thermo Fisher - Wako
List of Tables Major Companies Developing or Marketing AIDS Tests Major Companies Developing or Marketing Adenovirus Tests Major Companies Developing or Marketing Bartonella Tests Major Companies Developing or Marketing Campylobacter Tests Major Companies Developing or Marketing Candida Tests Major Companies Developing or Marketing Chlamydia Tests Major Companies Developing or Marketing Clostridium Tests Major Companies Developing or Marketing Coronavirus Tests Major Companies Developing or Marketing Cryptosporidium Tests Major Companies Developing or Marketing CMV Tests Major Companies Developing or Marketing Echovirus Tests Major Companies Developing or Marketing Enterovirus Tests Major Companies Developing or Marketing EBV Tests Major Companies Developing or Marketing Giardia Tests Major Companies Developing or Marketing Gonorrhea Tests Major Companies Developing or Marketing Hantavirus Tests Major Companies Developing or Marketing Helicobacter Pylori Tests Major Companies Developing or Marketing Hepatitis Tests Major Companies Developing or Marketing Herpes Tests Major Companies Developing or Marketing Influenza Tests Major Companies Developing or Marketing Legionella Tests Major Companies Developing or Marketing Lyme Disease Tests Major Companies Developing or Marketing Lymphogranuloma Tests Major Companies Developing or Marketing Malaria Tests Major Companies Developing or Marketing Measles Tests Major Companies Developing or Marketing Meningitis Tests Major Companies Developing or Marketing Microsporidium Tests Major Companies Developing or Marketing Mononucleosis Tests Major Companies Developing or Marketing Mumps Tests Major Companies Developing or Marketing Mycoplasma Tests Major Companies Developing or Marketing Papilloma Virus Tests Major Companies Developing or Marketing Parvovirus Tests Major Companies Developing or Marketing Pneumonia Tests Major Companies Developing or Marketing RSV Tests Major Companies Developing or Marketing Rotavirus Tests Major Companies Developing or Marketing Rubella Tests Major Companies Developing or Marketing Salmonella Tests Major Companies Developing or Marketing Septicemia Tests Major Companies Developing or Marketing Shigella Tests Major Companies Developing or Marketing Staphylococci Tests Major Companies Developing or Marketing Streptococci Tests Major Companies Developing or Marketing Syphilis Tests Major Companies Developing or Marketing Toxoplasmosis Tests Major Companies Developing or Marketing Trichomonas Tests Major Companies Developing or Marketing Tuberculosis Tests Major Companies Developing or Marketing West Nile Tests Major Companies Developing or Marketing Yersinia Tests Japan Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment Japan Hospital Laboratories Performing Infectious Disease Tests by Bed Size Japan Hospital Laboratories Infectious Disease Test Volume Forecast Japan Hospital Laboratories Infectious Disease Diagnostics Market Forecast Japan AIDS Testing Market Diagnostics Sales by Major Supplier Japan Campylobacter Testing Market Diagnostics Sales by Major Supplier Japan Candida Testing Market Diagnostics Sales by Major Supplier Japan Chlamydia Testing Market Diagnostics Sales by Major Supplier Japan CMV Testing Market Diagnostics Sales by Major Supplier Japan Gonorrhea Testing Market Diagnostics Sales by Major Supplier Japan Hepatitis Testing Market Diagnostics Sales by Major Supplier Japan Hepatitis C Testing Market Diagnostics Sales by Major Supplier Japan Herpes Testing Market Diagnostics Sales by Major Supplier Japan Legionella Testing Market Diagnostics Sales Forecast by Major Supplier Japan Meningitis Testing Market Diagnostics Sales by Major Supplier Japan Mononucleosis Testing Market Diagnostics Sales by Major Supplier Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier Japan Pneumonia Testing Market Diagnostics Sales by Major Supplier Japan RSV Testing Market Diagnostics Sales by Major Supplier Japan Rotavirus Testing Market Diagnostics Sales by Major Supplier Japan Rubella Testing Market Diagnostics Sales by Major Supplier Japan Septicemia Testing Market Diagnostics Sales by Major Supplier Japan Shigella Testing Market Diagnostics Sales by Major Supplier Japan Streptococci Testing Market Diagnostics Sales by Major Supplier Japan Syphilis Testing Market Diagnostics Sales by Major Supplier Japan Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier Japan Trichomonas Testing Market Diagnostics Sales by Major Supplier Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier
この商品のレポートナンバー
Blood Grouping Reagents Market Research Report: - Forecast till 2027
2022/02/22
4,950 USD
Gene Therapy Global Market Report 2023
2023/02/02
5,000 USD
Global Stem Cell Banking Market 2024-2028
2023/10/31
2,500 USD
Motion Sickness Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type
2024/04/03
3,500 USD
Actinomycin D for Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application
2024/04/22
House Dust Mite Allergy Treatment Market Research Report- Forecast to 2032
2024/10/01